T cell PKC expression as a novel neonatal predictor and modulator of allergic disease.

T 细胞 PKC 表达作为过敏性疾病的新型新生儿预测因子和调节因子。

• 批准号: nhmrc : 513709
• 负责人: A/Pr Charles Hii
• 金额: $ 37.2万
• 依托单位: The University of Western Australia
• 依托单位国家: 澳大利亚
• 项目类别: NHMRC Project Grants
• 财政年份: 2008
• 资助国家: 澳大利亚
• 起止时间: 2008-01-01 至 2012-12-31
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/t-cell-pkc-allergic-disease/99174
• 关键词: cell; PKC; expression; novel; neonatal

This application will further assess the role of a novel biological predictor of allergic disease, which appears more accurate than any previous marker (based on preliminary data). This is highly relevant to development of predictive tools that could be ultimately used in clinical practice. We will also assess this marker as a potential target for disease prevention, as our preliminary data also indicates that it can be modified by an early intervention aimed at preventing allergic disease.

该应用程序将进一步评估过敏性疾病的一种新的生物学预测因子的作用，它似乎比以往任何标记（基于初步数据）都更准确。这与最终可用于临床实践的预测工具的开发高度相关。我们还将评估该标记物作为疾病预防的潜在靶标，因为我们的初步数据还表明，它可以通过旨在预防过敏性疾病的早期干预进行修改。